Minimal Invasive Surgery for Gastric Subepithelial Tumor
Different Approach of Minimal Invasive Surgery for Gastric Subepithelial Tumor From A Single-Center Experience
1 other identifier
observational
194
0 countries
N/A
Brief Summary
The investigators conducted a retrospective study of those patients with gastric SETs receiving ER or LR at the operative theater in the single institution from January 2013 to December 2021. Medical records were retrospectively reviewed to define patient/tumor characteristics and operative outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2013
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedFirst Submitted
Initial submission to the registry
June 29, 2022
CompletedFirst Posted
Study publicly available on registry
July 11, 2022
CompletedJuly 11, 2022
July 1, 2022
9 years
June 29, 2022
July 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Procedure duration
minutes of procedure time
during the procedure/surgery
Length of hospital stay
days of hospitalization
upto one month after surgery
Rate of postoperative major complications
complications required further intervention, clavien dindo classification upto Grade III
upto one month after surgery
Study Arms (2)
endoscopic resection (ER)
ER with backup surgery was indicated for patients with endoscopic intent, and a small tumor size tolerated endoscopic retrieval.
laparoscopic resection (LR)
LR was indicated for patients with surgical intent, and those with the following conditions, which were not suitable for ER: (1) large tumor size with difficult endoscopic retrieval ; (2) symptoms of gastrointestinal tract bleeding with difficulty in endoscopic visualization; (3) suspicion of tumor rupture that required intra-abdominal exploration; and (4) histologic diagnosis of GIST with initial treatment of target therapy.
Interventions
Complete resection of gastric SETs was recommended if the tumor size was \>2 cm, presence of malignant features, or if the patient was symptomatic, declined periodical surveillance, and preferred to undergo diagnostic and therapeutic resection.
Eligibility Criteria
patients with gastric SETs who underwent ER or LR at the operative theater in our institution
You may qualify if:
- patients with gastric subepithelial tumors
- patients received minimal invasive surgery (endoscopy or laparoscopy) for tumor resection
You may not qualify if:
- patients had gastric anatomic changes due to previous surgery
- patients converted open surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2022
First Posted
July 11, 2022
Study Start
January 1, 2013
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
July 11, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share